GKB Ophthalmics (BOM:533212) Accounts Payable: ₹563 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533212 GKB Ophthalmics Ltd BOM:533212
54 GF Score
Price ₹63.56
GF Value ₹164.95
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GKB Ophthalmics Accounts Payable?

GKB Ophthalmics BOM:533212 +2.68% 54 Accounts Payable is ₹563 Mil as of Mar. 2026. GuruFocus rates BOM:533212 with a GF Score™ of 54/100 and a GF Value™ of ₹164.95 (Significantly Undervalued). The stock has 5 warning signs investors should review.

GKB Ophthalmics's Accounts Payable for the quarter that ended in Mar. 2026 was ₹563 Mil.

GKB Ophthalmics's quarterly Accounts Payable declined from Sep. 2025 (₹493 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹563 Mil).

GKB Ophthalmics's annual Accounts Payable increased from Mar. 2024 (₹331 Mil) to Mar. 2025 (₹393 Mil) and increased from Mar. 2025 (₹393 Mil) to Mar. 2026 (₹563 Mil).

GKB Ophthalmics Accounts Payable Related Terms

GKB Ophthalmics Accounts Payable Historical Data

* Premium members only.

The historical data trend for GKB Ophthalmics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GKB Ophthalmics Accounts Payable Chart

GKB Ophthalmics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 255.66 237.94 330.94 392.86 562.91

GKB Ophthalmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 392.86 0.00 493.42 0.00 562.91
BOM:533212
54GF Score
GKB Ophthalmics Ltd BOM:533212
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GKB Ophthalmics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹563 Mil mean?
GKB Ophthalmics (BOM:533212) has a Accounts Payable of ₹563 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on GKB Ophthalmics and its competitors.
Is GKB Ophthalmics' Accounts Payable too high?
GKB Ophthalmics' current Accounts Payable is ₹563 Mil. Overall, GKB Ophthalmics has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Accounts Payable compare to ISRG and BDX?
GKB Ophthalmics' Accounts Payable of ₹563 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on GKB Ophthalmics and its competitors. GKB Ophthalmics's current Accounts Payable is ₹563 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹164.95, compared to a current price of ₹63.56 — trading 61.5% below its estimated fair value. The current Accounts Payable is ₹563 Mil. GKB Ophthalmics' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Accounts Payable is ₹563 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?

Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued. The current stock price of ₹63.56 is trading 61.5% below its estimated GF Value™ of ₹164.95. GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.

Key valuation signals for BOM:533212:

  • Accounts Payable: ₹563 Mil
  • GF Value™: ₹164.95 vs. price of ₹63.56 (61.5% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GKB Ophthalmics Business Description

Address 16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
54GF Score

Get the complete analysis for BOM:533212

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹63.56
Price
₹164.95
GF Value